Supporting the notion, PD-L1 (encoded by CD274) is the most significantly upregulated protein in LATS2-mutant MPM (Figure S7A), and LATS1/2 deletion has recently been shown to enhance anti-tumor immune responses [28]. This evidence concerns the gene LATS1 and neoplasm.